Drug intelligence / Profile preview

4-n-butylresorcinol

Development stage
Unknown
Lead developer
POLA
Modality
Small Molecules
Administration
Topical
01

Overview

**4-n-butylresorcinol** (Kopcinol) is a synthetic small molecule and a derivative of resorcinol, primarily used as a topical agent for the treatment of hyperpigmentation disorders like melasma. Its main mechanism is potent inhibition of tyrosinase and tyrosinase-related protein-1 (TRP-1), key enzymes responsible for melanin synthesis in the skin, leading to skin lightening and brightening effects. 4-n-butylresorcinol has been shown to have greater hypopigmenting efficacy compared to established agents such as hydroquinone, arbutin, and kojic acid. It is approved in over-the-counter products for skin whitening, usually in cream or lotion formulations at concentrations up to 0.3%. Clinical studies support its efficacy and safety in hyperpigmentation, although higher concentrations or improper use may cause skin irritation.

Brand names
KopcinolRucinol
Other names
4-n-butyl resorcinol4-butylresorcin2,4-dihydroxy-n-butyl benzeneResorcinol, 4-butyl-4-(2,4-dihydroxyphenyl)butane
02

Targets

TYR (Tyrosinase)TYRP1 (Tyrosinase-related protein 1)

Beyond the preview

Go deeper on 4-n-butylresorcinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-n-butylresorcinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call